Supplementary Data from Constitutive Activation of RAS/MAPK Pathway Cooperates with Trisomy 21 and Is Therapeutically Exploitable in Down Syndrome B-cell Leukemia
Anouchka P. Laurent(Inserm), Sébastien Malinge(The Kids Research Institute Australia), Rishi S. Kotecha(The Kids Research Institute Australia), Beat Bornhäuser(University Children's Hospital Zurich), Carole Barin Bonnigal(Centre Hospitalier Universitaire de Tours), Éric Delabesse(Hôpital Necker-Enfants Malades), Laurence C. Cheung(The Kids Research Institute Australia), Thomas Mercher(Inserm), Silvia Jenni(University Children's Hospital Zurich), Estelle Daudigeos(Inserm), Zakia Aid(Inserm), Birgit Geoerger(Inserm), Paola Ballerini(Sorbonne Université), Jean‐Pierre Bourquin(University Children's Hospital Zurich), Stéphanie Lagarde(Université Toulouse III - Paul Sabatier), Olivier Bernard(Université de Poitiers), Muriel Gaudry(Inserm), Elizabeth Macintyre(Inserm), Aurélie Siret(Inserm), Gaëlle Pierron(Institut Curie), John D. Crispino(St. Jude Children's Research Hospital), Yann Lécluse(Institut Gustave Roussy), Damien Roos‐Weil(Sorbonne Université), Kunjal Panchal(The Kids Research Institute Australia), Nathalie Droin(Centre National de la Recherche Scientifique), Naïs Prade(Université Toulouse III - Paul Sabatier), Yi-Chien Tsai, Damien Plassard(Centre National de la Recherche Scientifique), Cathy Ignacimouttou(Inserm), M’Boyba Diop(Institut Gustave Roussy)
Cited by 0
Related Papers
<i>LMO2</i> -Associated Clonal T Cell Proliferation in Two Patients after Gene Therapy for SCID-X1
|Science|2003|3.5k
Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis
|Cancer Cell|2005|3k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
|Molecular Cancer|2023|1.9k